Evidence map›Paper›PMID 40636462›Full record

ReviewiLIVER2025

Practice revolution in local interventional therapy for liver metastases.

Hongjun Yuan, Hongli Yu, Ying Guan, Wenjing Wang, Qiang Yu, Yinying Lu, Fengyong Liu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in iLIVER, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hongjun YuanDepartment of Interventional Radiology, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China.
Hongli YuComprehensive Liver Cancer Center, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China.
Ying GuanDepartment of Interventional Radiology, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China.
Wenjing WangComprehensive Liver Cancer Center, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China.
Qiang YuDepartment of Interventional Radiology, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China.
Yinying LuComprehensive Liver Cancer Center, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China.
Fengyong LiuDepartment of Interventional Radiology, The 5th Medical Center of the PLA General Hospital, Beijing 100039, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of liver metastases is undergoing a transformation from single-modality therapy to multimodal combination therapy, with local interventional treatments playing an increasingly important role. This review explores the synergistic effects between local interventional therapy and systemic treatment, the reconstruction of interventional therapy indications driven by advances in systemic treatment, and the impact of local interventional therapy on systemic treatment "switching" strategies. Through multidisciplinary collaboration and innovative interventional materials and techniques, local interventional therapy has evolved from a traditional palliative approach to become an essential component in the comprehensive treatment system for liver metastases.

Indexed as

Liver metastasesLocal interventional therapySystemic therapyTreatment strategy

Identifiers

PMID40636462
PMCPMC12209472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.